NINNA NANA: Open Payments
NPI 1114511797 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 78 payments from 19 companies in 2025. Trend: 2023 $2,419 · 2024 $1,693 · 2025 $1,811
Food & beverage: $1,800Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $529 |
| Madrigal Pharmaceuticals | 8 | $474 |
| Janssen Biotech, Inc. | 4 | $190 |
| PFIZER INC. | 8 | $139 |
| Regeneron Healthcare Solutions, Inc. | 5 | $123 |
| Ardelyx, Inc. | 4 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $48 |
| GENZYME CORPORATION | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: REZDIFFRA, TREMFYA, LINZESS, DUPIXENT, CREON, RINVOQ, SKYRIZI, XELJANZ.
Industry payments across MD — which companies pay providers there.
